LucyRx Announces New Investment from LRVHealth to Drive Innovation and Expand Access to Smarter Pharmacy Benefits
This investment reflects a growing demand for pharmacy innovation among health systems
BETHESDA, Md., April 15, 2025--(BUSINESS WIRE)--LucyRx, a next-generation pharmacy benefits manager (PBM), today announced a strategic growth investment from LRVHealth, a healthcare investment platform backed by a national network of leading health systems. With this funding, LRVHealth joins LucyRx's existing investor base, bringing the company's total committed capital to more than $500 million.
The investment recognizes LucyRx's role in transforming the PBM industry and will further scale the company's technology-enabled platform, expand client partnerships, and ultimately enhance prescription drug access and affordability.
"This partnership marks a pivotal moment for LucyRx as we continue our mission to rethink what's possible in pharmacy benefits," said David Blair, CEO of LucyRx. "LRVHealth's deep industry expertise and strategic network will help accelerate our growth, broaden our impact, and bring our high-touch, client-first PBM approach to more employers, payers, and members."
Accelerating Innovation & Expanding Reach
With employers and payers demanding greater clarity, flexibility, and control over pharmacy benefits, LucyRx is setting a new standard in the prescription benefit industry—one that combines advanced technology with a commitment to high-touch service. The investment will accelerate:
Expansion of LucyRx's technology-driven PBM model, delivering cost efficiency, personalized support, and plan flexibility.
Customizable solutions that simplify formulary management, reduce administrative complexity, and improve medication adherence—while driving down overall costs.
Advanced analytics and AI-powered tools through LucyIQ™, enabling smarter decision-making for plan sponsors and members.
"As pharmacy benefits continue to evolve, we see strong alignment between LucyRx's solutions and the needs of our health system partners," said Tripp Peake, Managing Partner at LRVHealth. "There is tremendous potential in their model, and we are excited to support David and the LucyRx team."
A Shared Vision for Impact
The investment aligns with LRVHealth's mission-driven approach to creating meaningful health and social impact through three core pillars:
Creating Healthier Communities
Expanding Access to Care
Building Sustainable Healthcare Systems
LucyRx is committed to creating healthier communities and expanding access to care through an accountable, patient-first approach to pharmacy benefits.
About LucyRx
LucyRx is an independent, next-generation pharmacy benefit manager (PBM) redefining prescription care. Fueled by innovation and decades of leadership experience, LucyRx delivers better outcomes through its integrated specialty network, formulary marketplace, and next-day home delivery solutions. Powered by its proprietary AI platform, LucyIQ™, the company provides real-time insights that support evidence-based clinical decisions, clear pricing, and exceptional service from U.S.-based pharmacy technicians. Partnering with more than 60,000 pharmacies, LucyRx serves over 1,200 clients nationwide.
This is prescription care, brilliantly reimagined.Learn more at LucyRx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250415481334/en/
Contacts
Media Contact Tricia Bancroft516-241-6157press@lucyrx.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Rio Tinto seeks innovative collaborators at London Tech Week
LONDON, June 09, 2025--(BUSINESS WIRE)--Rio Tinto is taking its innovation strategy directly to entrepreneurs, researchers and innovators at London Tech Week as it works to accelerate the breakthroughs needed to sustainably deliver the materials the world needs. The only mining company at London Tech Week, Rio Tinto will lead discussions on how to meet the soaring global demand for critical minerals, deliver materials at scale more sustainably, and harness innovation to deliver the technologies of tomorrow, from AI to electrification to renewables. Rio Tinto Chief Innovation Officer Dan Walker said: "Innovation is in our DNA. For over 150 years, Rio Tinto has operated at the intersection of mining and technology, and there has never been a time when innovation is needed more. "As the world faces increasingly complex challenges, from climate change and urbanisation to the energy transition and electrification, meeting the world's needs requires more materials, delivered faster, more sustainably, and with a lighter footprint at every step. "These are deeply complex issues that no organisation can solve alone. We want to find the very best innovators and entrepreneurs to join our global network of startups, universities, tech leaders and governments to help turn bold ideas into real-world solutions." Rio Tinto's expanding innovation ecosystem includes its Accelerator Program, run in partnership with early-stage investor Founders Factory, and its Ventures Fund, which support high-potential startups mining and sustainability. Last year, Rio Tinto also invested $150 million to launch the Rio Tinto Centre for Future Materials, in collaboration with five world-leading universities, to advance transformational research to accelerate progress towards net zero. Led by Imperial College London, the academic partners include The University of British Columbia, Vancouver; The University of California, Berkeley; The University of the Witwatersrand, Johannesburg; and The Australian National University, Canberra. Rio Tinto speaking sessions at London Tech Week 2025: Monday 9 June: "Unlocking tomorrow's tech: powering innovation that ensures the sustainable supply of the materials that matter" — Rio Tinto CEO Jakob Stausholm in conversation with Dan Walker, Chief Innovation Officer (Main Stage) Wednesday 11 June: "Creating the Future from Campus: Why Are University Spinouts So Important for Innovation?" — Panel featuring Marie-Pierre Paquin, Rio Tinto Head of Science & Partnerships (Founders Stage) Wednesday 11 June: "Why the future depends on blurring the lines between Mining and ClimateTech" — Panel moderated by Pekka Santasalo, Rio Tinto Head of Growth & Ventures, with founders from three startups backed by Rio Tinto (Impact Stage) View source version on Contacts Please direct all enquiries to Media Relations, United Kingdom Matthew Klar M +44 7796 630 637David Outhwaite M +44 7787 597 493 Media Relations, Australia Matt Chambers M +61 433 525 739Michelle Lee M +61 458 609 322Rachel Pupazzoni M +61 438 875 469 Media Relations, Canada Simon Letendre M +1 514 796 4973Malika Cherry M +1 418 592 7293Vanessa Damha M +1 514 715 2152 Media Relations, US Jesse Riseborough M +1 202 394 9480 Rio Tinto plc 6 St James's SquareLondon SW1Y 4ADUnited KingdomT +44 20 7781 2000Registered in EnglandNo. 719885 Rio Tinto Limited Level 43, 120 Collins StreetMelbourne 3000AustraliaT +61 3 9283 3333Registered in AustraliaABN 96 004 458 404 Category: General
Business Wire
38 minutes ago
- Business Wire
Rio Tinto seeks innovative collaborators at London Tech Week
LONDON--(BUSINESS WIRE)--Rio Tinto is taking its innovation strategy directly to entrepreneurs, researchers and innovators at London Tech Week as it works to accelerate the breakthroughs needed to sustainably deliver the materials the world needs. The only mining company at London Tech Week, Rio Tinto will lead discussions on how to meet the soaring global demand for critical minerals, deliver materials at scale more sustainably, and harness innovation to deliver the technologies of tomorrow, from AI to electrification to renewables. Rio Tinto Chief Innovation Officer Dan Walker said: 'Innovation is in our DNA. For over 150 years, Rio Tinto has operated at the intersection of mining and technology, and there has never been a time when innovation is needed more. 'As the world faces increasingly complex challenges, from climate change and urbanisation to the energy transition and electrification, meeting the world's needs requires more materials, delivered faster, more sustainably, and with a lighter footprint at every step. 'These are deeply complex issues that no organisation can solve alone. We want to find the very best innovators and entrepreneurs to join our global network of startups, universities, tech leaders and governments to help turn bold ideas into real-world solutions.' Rio Tinto's expanding innovation ecosystem includes its Accelerator Program, run in partnership with early-stage investor Founders Factory, and its Ventures Fund, which support high-potential startups mining and sustainability. Last year, Rio Tinto also invested $150 million to launch the Rio Tinto Centre for Future Materials, in collaboration with five world-leading universities, to advance transformational research to accelerate progress towards net zero. Led by Imperial College London, the academic partners include The University of British Columbia, Vancouver; The University of California, Berkeley; The University of the Witwatersrand, Johannesburg; and The Australian National University, Canberra. Rio Tinto speaking sessions at London Tech Week 2025: Monday 9 June:"Unlocking tomorrow's tech: powering innovation that ensures the sustainable supply of the materials that matter' — Rio Tinto CEO Jakob Stausholm in conversation with Dan Walker, Chief Innovation Officer (Main Stage) Wednesday 11 June:"Creating the Future from Campus: Why Are University Spinouts So Important for Innovation?' — Panel featuring Marie-Pierre Paquin, Rio Tinto Head of Science & Partnerships (Founders Stage) Wednesday 11 June: "Why the future depends on blurring the lines between Mining and ClimateTech" — Panel moderated by Pekka Santasalo, Rio Tinto Head of Growth & Ventures, with founders from three startups backed by Rio Tinto (Impact Stage)
Yahoo
3 hours ago
- Yahoo
28bio Announces Nexon™ Neurotechnology Platform Powered by Engineered Human Brains
Exhibits complex neurological processes—including memory, learning, and cognition—and predicts human outcomes in preclinical drug development NEW ORLEANS, June 9, 2025 /PRNewswire/ -- 28bio today announced the Nexon™ neurotechnology platform—a major advancement in understanding human brain function. The platform integrates tissue engineering, neural interfacing and AI to engineer human brains at-scale and replicate complex neurological processes. The Nexon™ platform is now being used to improve the prediction of therapeutic efficacy and toxicity in humans, with several of the world's largest pharma companies already integrating Nexon™ into their drug development workflows. The Nexon™ platform also incorporates Organoid Intelligence (OI). The growing field of OI combines human brain organoids with brain-machine interfaces to model memory, learning, and cognition in vitro, offering novel functional cognitive biomarkers with the potential to reshape drug development in neurodegenerative disorders including Alzheimer's disease. Neurological drug development faces some of the highest failure rates in the pharmaceutical industry, due to poor translatability of animal models. Despite promising preclinical study results, many therapies ultimately fail in humans—contributing to a growing neurological health crisis and need for more predictive, human-relevant models. "We engineer human brains capable of elucidating the complexity of neurological processes and produce predictive data needed to change the trajectory of neurological drug development," said Alif Saleh, CEO of 28bio. "Industry and regulators are urgently asking for solutions to develop better neurological drugs faster and cheaper." About 28bio28bio is a neurotechnology company engineering human brains at-scale exhibiting memory, learning, and cognitive functions. Its Nexon™ platform integrates tissue engineering, neural interfacing, and AI to reverse today's neurological health crisis by improving the ability to predict which therapies will work in humans. 28bio is committed to advancing ethical standards in the development of brain organoid technology and engineered human cognition. For more information, visit View original content to download multimedia: SOURCE 28bio Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
